Neumedicines Inc.
Get Full AccessDescription
- Neumedicines Inc. is an emerging therapeutic biotechnology company focused on developing and commercializing innovative and proprietary products and approaches that address unmet clinical and societal needs in the areas of oncology, hematology, and immunology. The company operates from its headquarters in Pasadena, California.Neumedicines' lead product candidate is recombinant human interleukin-12 (rHuIL-12), a heterodimeric glycoprotein and cytokine. rHuIL-12 is being developed under the trade name HemaMax for various clinical indications, including hematopoietic syndrome of acute radiation syndrome (HSARS), skin cancers and other solid tumors, and blood disorders and malignancies.
-
Headquarters:133 North Altadena Drive , Pasadena, California, United States
More -
Phone Number: +1 626-844-3800
-
Website: https://www.neumedicines.com
-
Employees:10
-
Revenue:$10 - 50M
-
Legal Name:Neumedicines Inc.
-
Neumedicines Inc.'s Social Media
-
Is this data correct?
-
| NAICS Code: 621511 |
Show More
Frequently Asked Questions regarding Neumedicines Inc.
-
Where are Neumedicines Inc.'s Headquarters?
Neumedicines Inc.'s Headquarters are in 133 North Altadena Drive ,Pasadena,California,United States
-
What is Neumedicines Inc.'s phone number?
Neumedicines Inc.'s phone number is +1 626-844-3800
-
What is Neumedicines Inc.'s official website?
Neumedicines Inc.'s official website is https://www.neumedicines.com
-
What is Neumedicines Inc.'s Revenue?
Neumedicines Inc.'s revenue is $10 - 50M
-
What is Neumedicines Inc.'s NAICS code?
Neumedicines Inc.'s NAICS code is 621511
-
How many employees are working in Neumedicines Inc.
Neumedicines Inc. has 10 employees
-
What is Neumedicines Inc.'s Industry?
Neumedicines Inc. is in the industry of Biotechnology
-
Who is Neumedicines Inc.'s Vice President, Drug Development?
Neumedicines Inc.'s Vice President, Drug Development is Chris Lawrence

